Barrington raised the firm’s price target on Merit Medical (MMSI) to $106 from $103 and keeps an Outperform rating on the shares after the company reported “strong” Q3 results and increased its FY25 guidance “materially.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target raised to $103 from $102 at Baird
- Merit Medical price target raised to $109 from $105 at Piper Sandler
- Cautious Hold Rating for Merit Medical Systems Amid Strong Q3 and Transitional Challenges
- Merit Medical Systems: Strong Financial Performance and Strategic Growth Drive Buy Rating
- Merit Medical Reports Strong Q3 2025 Growth